H. Magnussen (Grosshansdorf, Germany), Z. Diamant (Leiden, The Netherlands)
Non inferiority comparison of salmeterol HFA (SM-HFA) pMDI with salmeterol CFC (SM-CFC) pMDI in patients with symptomatic asthma
N. Raval, T. MohanKumar, R. Bhagat, R. Reddy, D. J. Christopher, S. Naik, C. J. Po, S. M. Purandare, A. Sule, J. A. Gogtay (Ahmedabad, Coimbatore, Hyderabad, Vellore, Mumbai, India)
|  |
Budesonide/formoterol for maintenance and relief vs. higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS)
P. Kuna, M. Peters, R. Buhl (Lodz, Poland; Concord, Australia; Mainz, Germany)
|  |
Non-inferiority comparison of formoterol HFA (FM-HFA) pMDI with formoterol CFC (FM-CFC) pMDI in patients with symptomatic asthma
P. Mahesh, P. Niphadkar, J. Joshi, K. Jagannath, G. Dsouza, C. J. Po, S. M. Purandare, A. Sule, P. A. Kotnis, J. A. Gogtay (Mysore, Mumbai, Chennai, Bangalore, India)
| |
Open-label, randomized, comparative trail of the efficacy of the azithromycin in the 8-week treatment of mild-to-moderate asthma
Y. Belotserkovskaya, A. Sinopalnikov (Moscow, Russian Federation)
| |
PK and PD of a new beclomethasone dipropionate and formoterol CFC-free fixed combination
A. Piccinno, G. Poli, D. Acerbi, I. Burton, X. Druart (Parma, Italy; Wavre, Belgium)
| |
Budesonide/formoterol as maintenance and reliever therapy in uncontrolled asthma compared with high dose salmeterol/fluticasone: the AHEAD double-blind study
J. Bousquet, L. P. Boulet (Montpellier, France; Québec, Canada)
| |
Specific allergen immunotherapy might be safer than previous assumed when performed correct
F. Madsen, L. Frølund, M. Christensen, A. Frost, U. Søes-Petersen (Ellsinore, Hellerup, Åbemnrå, Denmark)
| |
Interactions between the β2 adrenoceptor and the COX enzyme system during relaxation in guinea pig trachea
M. van Loon, A. K. Larsson, B. Waldeck, M. Andersson, S. E. Dahlén (Stockholm, Sweden)
| |
Assessment of the potency and duration of action of aclidinium bromide in guinea pig isolated trachea in vitro
M. Miralpeix, A. Gavalda, E. Morcillo, J. Cortijo, J. Puig, H. Ryder, J. Beleta (Barcelona, Valencia, Spain)
| |
New twists in the pharmacology of NSAID drugs
C. Buccellati, E. Selg, M. Andersson, G. Rovati, M. Ezinga, A. Sala, A. K. Larsson, E. Ambrosio, L. Lastbom, V. Capra, B. Dahlen, A. Ryrfeldt, S. E. Dahlen, G. Folco (Milan, Italy; Stockholm, Sweden)
| |
Nitric oxide inhibition in guinea pigs with chronic allergic inflammation: effects on lung tissue strip mechanics
E. A. Leick-Maldonado, C. M. Starling, C. M. Prado, T. Lanças, F. G. dos Reis, L. R. C. R. B. Aristóteles, M. Dolhnikoff, M. A. Martins, I. F. L. C. Tibério (São Paulo, Brazil)
| |
P38 MAPK and MMP-9 mediate airway mucus hypersecretion induced by acrolein
D. S. Liu, F. Q. Wen, Y. P. Li, D. Xu, R. Qiu (Chengdu, Sichuan, China)
| |
The chemokines MDC and TARC require the presence of activated platelets to enhance the formation of platelet-neutrophil conjugates
K. N. Kornerup, G. P. Salmon, S. C. Pitchford, W. L. Liu, C. P. Page (London, Sandwich, United Kingdom)
| |
Associations between genetic polymorphisms and drug response phenotypes in patients with asthma
D. Paul, H. Ortega, Y. Steve, L. Edwards, A. Morris, L. Sutton, N. Galwey, M. Nelson, L. Hosking, W. Anderson (Research Triangle Park, NC, United States Of America)
| |
Asthma control and exhaled nitric oxide in asthmatic patients with severe obesity after weight loss
M. Maniscalco, A. Zedda, S. Faraone, M. R. Cerbone, S. Cristiano, C. Giardiello, M. Sofia (Casoria (Naples), Naples, Italy)
| |
Effect of roflumilast on airway ciliary beat frequency in rat lung slices of proximal and distal airways
C. Braun, D. Marx, A. Weidenbach, R. Beume, J. Barsig (Konstanz, Germany)
| |
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
C. Dimitropoulou, C. Snead, L. Gao, J. Catravas (Augusta, United States Of America)
| |
Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsiveness and inflammation
L. Zhou, Y. Zhu, X. Cui, W. Xie, A. Hu, K. Yin (Nanjing, Jiangsu, China; Philadelphia, PA, United States Of America)
| |
Understanding the mechanisms of LASSBio596 on airway remodeling in asthma
P. Rocco, D. Xisto, M. Oliveira, P. Silva, D. Ornellas, H. Campos, T. Mauad, D. Carnielli, V. Capelozzi, L. Lima, E. Barreiro, W. Zin, J. Lapa e Silva, E. Negri, M. Morales (Rio de Janeiro, Sao Paulo, Brazil)
| |
Effect of ligustrazine inhalation on the expression of stem cells factor (SCF) in mouse asthma models
K. Yin, J. Liu, X. Zhang (Nanjing, China)
| |